Novugen Pharma Malaysia Sdn BHD
General
Total Cases1
Active Cases1
Patents--
Ratings
Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 01/13/25 | OPENING BRIEF in Support re [463] MOTION for Post Judgment Modification or Vacatur and Relief Pursuant to Federal Rule of Procedure 60(b), filed by MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals Inc..Answering Brief/Response due date per Local Rules is 1/27/2025. (Attachments: # [1] Exhibit 1)(Weinblatt, Richard) Modified on 1/13/2025 (nms). (Entered: 01/13/2025) | |
| 01/13/25 | MOTION for Post Judgment Modification or Vacatur and Relief Pursuant to Federal Rule of Procedure 60(b) - filed by MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # [1] Proposed Order)(Weinblatt, Richard) Modified on 1/13/2025 (nms). (Entered: 01/13/2025) | |
| 01/13/25 | ORDER of USCA as to [407] Notice of Appeal (Federal Circuit), filed by Novartis Pharmaceuticals Corporation. Decision of USCA: The Rule 8 motion, ECF No. 63, is denied as moot. The motion to clarify and continue the temporary injunction, ECF No. 105, is denied. The temporary relief provided in the courts August 14, 2024 order is lifted. (nms) (Entered: 01/13/2025) | |
| 01/13/25 | ORAL ORDER: MSN is directed to file a brief in opposition to Novartis's motion for injunctive relief (No. 19-2053, D.I. [456] ) by 8 p.m. January 14, 2025. The Court will hold a hearing on the motion on January 15, 2025 at 11 a.m. in courtroom 6A. Ordered by Judge Richard G. Andrews on 1/13/2025. (aas) Modified on 1/13/2025 (aas). (Entered: 01/13/2025) | |
| 01/13/25 | [SEALED] Letter to The Honorable Richard G. Andrews, from Daniel M. Silver, Esq., regarding Motion for Injunctive Relief Against MSN on U.S. Patent No. 8,101,659. (Attachments: # [1] Certificate of Service)(Silver, Daniel) Modified on 1/13/2025 (nms). (Entered: 01/13/2025) | |
| 01/13/25 | [SEALED] DECLARATION of Christopher E. Loh re [456] MOTION for Injunctive Relief Against MSN on U.S. Patent No. 8,101,659, by Novartis Pharmaceuticals Corporation. (Attachments: # [1] Exhibits 1-13, # [2] Certificate of Service)(Silver, Daniel) Modified on 1/13/2025 (nms). (Entered: 01/13/2025) | |
| 01/13/25 | [SEALED] OPENING BRIEF in Support re [456] MOTION for Injunctive Relief Against MSN on U.S. Patent No. 8,101,659 filed by Novartis Pharmaceuticals Corporation.Answering Brief/Response due date per Local Rules is 1/27/2025. (Attachments: # [1] Certificate of Service)(Silver, Daniel) (Entered: 01/13/2025) | |
| 01/13/25 | MOTION for Injunctive Relief Against MSN on U.S. Patent No. 8,101,659 - filed by Novartis Pharmaceuticals Corporation. (Attachments: # [1] Text of Proposed Order, # [2] Text of Proposed Order Final Judgment, # [3] 7.1.1. Certification)(Silver, Daniel) (Entered: 01/13/2025) | |
| 01/13/25 | ORAL ORDER Setting Emergency Teleconference: Plaintiff to initiate the call. A Telephone Conference is set for 1/10/2025, at 4:30 PM in Telephonically before Judge Richard G. Andrews. Ordered by Judge Richard G. Andrews on 1/10/2025. (aas) (Entered: 01/13/2025) | |
| 01/13/25 | Minute Entry for proceedings held before Judge Richard G. Andrews: Emergency Telephone Conference held on 1/10/2025. Counsel for Plaintiff: D. Silver. Counsel for Defendant: R. Weinblatt. The Court verbally issued a temporary restraining order to expire on 1/15/2025. (Court Reporter Deanna Warner.) (aas) (Entered: 01/13/2025) |